Author: Stocks Breaking News

Wheat prices on the Chicago and Kansas City futures markets reversed higher after a weaker session earlier in the week, lifting most contracts into post-midday gains. Chicago SRW futures were up roughly 6 to 7 cents across nearby positions, while Kansas City HRW futures rose about 13 to 14 cents, and Minneapolis spring wheat also followed through with gains of around 6 to 8 cents in front months. Traders pointed to renewed demand driven by heightened concern around the Black Sea, where Russia–Ukraine-related disruptions have reportedly intensified—moving from strikes to areas closer to ports and vessels operating on the water.…

Lean hog futures ended mixed on the day, with most contracts posting gains of 20 to 60 cents while the August contract fell 5 cents. The shift came alongside a slight dip in USDA’s national base hog price and continued sensitivity to export demand signals. USDA reported the national base hog price at $100.26 on Thursday afternoon, down 40 cents from the prior day. The CME Lean Hog Index rose 73 cents on July 14 to $94.60, offering some support to the complex even as nearby prices adjusted. Key takeaways Price move: Lean hog futures finished mixed; most contracts rose…

Midday trading saw a split between strong earnings-driven gains in parts of insurance and sharp declines across healthcare, streaming, semiconductors, and software, as investors weighed results, guidance signals, and company-specific headlines. Key movers included Travelers after a major quarterly beat, Netflix following an earnings-and-engagement update, and Intuitive Surgical after results triggered a double-digit selloff. Key takeaways Travelers surged nearly 8% after a large second-quarter earnings and revenue beat, underscoring investor appetite for clear fundamental upside. Netflix fell more than 7% despite reporting results in line with expectations, reflecting disappointment over streaming engagement signals and a reduction in the frequency of…

Cotton futures and key benchmark prices fell on Friday morning, extending weakness after traders moved lower late Thursday. Export sales data also pointed to slower demand and new-crop activity, reinforcing a cautious tone for the 2025/26 crop outlook. By early Friday, cotton futures were down roughly 95 to 105 points from Thursday’s close across the front months, while crude oil edged higher and the U.S. dollar index was also up. Key takeaways Price move: October 2026 cotton slid to a Friday morning level about 105 points lower versus Thursday’s finish, with other contracts also down around 95 to 105 points.…

US equity markets slid sharply on Wednesday, with the S&P 500 down 1.06%, the Dow Jones Industrial Average down 0.12%, and the Nasdaq 100 falling 2.23%. The selloff was led by a broad drop in chip and AI infrastructure stocks, as investors weighed concerns that blockbuster gains tied to artificial intelligence may be outpacing what elevated valuations can justify. Index futures pointed to further weakness into the session, with September E-mini S&P futures down 0.95% and September E-mini Nasdaq futures down 2.12%. Risk assets also weakened globally, while demand for Treasuries increased as investors rotated toward safety. Key takeaways Price…

Chicago and Kansas City wheat futures were mixed on Friday, with gains running roughly 3 to 8 cents across the three active contracts as the market pared back Thursday’s slide. Wheat prices had slipped the prior session, leaving traders focused on shipment pace from the U.S. and steady progress in key European harvests. Attention also centered on the latest USDA Export Sales report, which showed the weakest new-marketing-year weekly sales total to date, raising questions about how quickly export demand can rebuild after a slower start. Key takeaways Wheat prices were mixed on Friday, with contracts moving within a 3…

Stellar’s native token, XLM, is attempting to stabilize after a choppy week in which it tracked broader weakness in the cryptocurrency complex. XLM was trading at $0.1834, down 3% over 24 hours and extending its weekly decline to 4.3%, as investors weighed renewed uncertainty around U.S. crypto regulation. With no specific negative Stellar network headline driving the sell-off, market participants pointed to macro sentiment and cross-asset risk appetite—factors that tended to hit altcoins harder than Bitcoin. Investors are now watching a technical “golden cross” signal and the scheduled Stellar Protocol v25 upgrade on July 22 for potential direction. Key takeaways…

Corn futures finished lower in Thursday trading, with contracts across the curve slipping 4 to 6 cents. The U.S. national average cash corn price fell 6 3/4 cents to $4.10 3/4, after USDA’s latest weekly Export Sales report showed volume below expectations for both old-crop and near-term needs. Price action reflected a mix of weaker export demand signals and updated weather and production outlooks, even as the crop calendar remains sensitive to seasonal conditions across the Corn Belt. Key takeaways Price move: September 2026 corn closed at $4.41 1/2, down 6 cents; nearby cash corn fell to $4.10 3/4, down…

Cardano’s network upgrade, the Van Rossem hard fork, is scheduled to take effect tomorrow, sharpening focus on the ADA token as traders look for signs the update can halt the recent slide. ADA was trading at $0.1608 at the time of writing, down 1.0% over the prior 24 hours, while the broader picture remains soft with the token down 4.7% for the week and nearly 5% over the month. Ahead of the fork, on-chain signals point to accumulation by large holders, but derivatives positioning suggests investors are still split—an alignment that could keep volatility elevated around the upgrade window. Key…

Revolution Medicines shares have attracted fresh attention as the company prepares regulatory steps for daraxonrasib, its investigational treatment aimed at challenging chemotherapy in aggressive cancers. The stock has benefited from optimism around late-stage trial data and the company’s progress toward filings with U.S. and European regulators. Investors are also watching high-profile institutional support, including recent disclosed buying by Stanley Druckenmiller’s Duquesne Family Office, underscoring the market’s focus on the timing and likelihood of regulatory outcomes for the program. Key takeaways Price move: Revolution Medicines stock is up 125% this year, reflecting heightened expectations for regulatory decisions tied to daraxonrasib. Catalyst:…